Icon Wealth Partners’s Bio-Techne TECH Stock Holding History

Icon Wealth Partners’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$503K	Sell	7,392 -2,029	-22%	-$160K	0.06%	170
2023 Q2	$769K	Sell	9,421 -1,382	-13%	-$111K	0.08%	151
2023 Q1	$802K	Buy	+10,803	New	+$833K	0.09%	157
2022 Q2	$1.09M	Sell	12,620 -2,664	-17%	-$250K	0.13%	126
2022 Q1	$1.66M	Sell	15,284 -1,584	-9%	-$163K	0.16%	108
2021 Q4	$2.18M	Sell	16,868 -76	-0.4%	-$9.32K	0.22%	105
2021 Q3	$2.05M	Buy	16,944 +864	+5%	+$105K	0.22%	105
2021 Q2	$1.81M	Buy	16,080 +2,000	+14%	+$211K	0.19%	112
2021 Q1	$1.34M	Buy	14,080 +2,980	+27%	+$272K	0.17%	117
2020 Q4	$881K	Buy	11,100 +2,384	+27%	+$173K	0.14%	125
2020 Q3	$540K	Buy	+8,716	New	+$567K	0.1%	138
2019 Q2	–	Sell	-1,164	Closed	-$58K	–	696
2019 Q1	$58K	Buy	+1,164	New	+$52.4K	0.02%	326
2018 Q3	–	Sell	-1,228	Closed	-$45K	–	675
2018 Q2	$45K	Buy	+1,228	New	+$46.9K	0.02%	409
2018 Q1	–	Sell	-1,228	Closed	-$40K	–	671
2017 Q4	$40K	Buy	+1,228	New	+$39K	0.02%	464

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Icon Wealth Partners's TECH Position: Q3 2023 in Review

Icon Wealth Partners reduced its Bio-Techne (TECH) stake by 22% in Q3 2023, selling an estimated $160K and leaving 7,392 shares worth $503K. The position accounts for 0.06% of the portfolio, ranked #170.

Icon Wealth Partners first reported a position in TECH in Q4 2017 and has held it in 14 quarters since. The position peaked at $2.18M in Q4 2021. 529 funds tracked by Wall St. Rank hold TECH as of Q3 2023.

Icon Wealth Partners held 7,392 shares of Bio-Techne worth $503K as of Q3 2023.
Icon Wealth Partners sold 2,029 Bio-Techne shares in Q3 2023, an estimated $160K.
Bio-Techne made up 0.06% of Icon Wealth Partners's portfolio in Q3 2023, its #170 holding.
Icon Wealth Partners first reported a position in Bio-Techne in Q4 2017 and has held it in 14 quarters since.
Icon Wealth Partners's Bio-Techne position peaked at $2.18M in Q4 2021.
529 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2023.

Based on Icon Wealth Partners's 13F filing for Q3 2023, filed 14 Nov 2023.